Fonar Corporation news

   Watch this stock
Showing stories 1 - 10 of about 72   

Articles published

FONR 13.83 -0.48 (-3.35%)
price chart
Analysis and Fonar Corporation (FONR) Earnings Review
Analysts await Fonar Corporation (NASDAQ:FONR) to reports earnings on February, 8. The stock decreased 3.35% or $0.48 on February 5, hitting $13.83.
Fonar: Caught Between A Rock And A Hard Place
Fonar's last quarter was in line with what I expected. No surprises and boring. And even if the stock is relatively cheap, it sold off very badly.
Fonar: A Micro-Cap With 40% Upside (FONR)
Fonar Corporation (NASDAQ:FONR) is not a new name in MRI. In fact, the company's founder (and still CEO), Raymond Damadian, invented the MRI machine back in 1972.
Hedge Funds Are Crazy For Fonar Corp (NASDAQ:FONR)
Fonar Corp (NASDAQ:FONR) hedge funds sentiment increased to 1.19 in Q2 2015. Its up 0.40, from 0.79 in 2015Q1. The sentiment improved, as 19 active investment managers opened new and increased stock positions, while 16 sold and decreased their ...
Fonar Corporation (FONR) news: What Should Investors Do With Fonar?
Currently Fonar's market cap is about $140 million, with sales projected to be about $70 million for 2014 and EPS about $1.25 per share.
Related articles »  
Fonar - Unknown And Undervalued (FONR)
Fonar Corporation (NASDAQ:FONR) is engaged in the research, development, productions, and marketing of medical scanning equipment, which uses principles of Magnetic Resonance Imaging (MRI) for the detection of and diagnosis of human diseases.
Related articles »  
What's Hot Today: Fonar Corp. (NASDAQ:FONR), American Midstream Partners, LP ...
On 6 January, FONAR Corporation (NASDAQ:FONR), reported that its subsidiary Health Management Company of America, LLC (HMCA) is now managing Stand-Up MRI of Great Neck, located at 600 Northern Blvd.
FONAR Announces Fiscal 2015 2nd Quarter Financial Results
FONAR Corporation ( NASDAQ : FONR ), The Inventor of MR Scanning™, reported its second quarter fiscal 2015 results for the quarter ended December 31, 2014.
Fonar Is An Unusual And Undervalued Play On The Obesity Epidemic (FONR)
Fonar Corp. (NASDAQ:FONR) is an undervalued stock in the medical field that will benefit from the obesity epidemic in the United States and abroad in an unusual way.
Related articles »  
Morning Watch: Fonar Corp. (FONR), Novavax (NVAX), Apple (AAPL), Microsoft ...
Shares of Fonar Corp. (FONR) are down $2.49 to $15.60 after the company released its earnings results on Monday. The Melville, New York-based company reported Q1'16 EPS of $0.43 per share vs.